What people call a “hangover” is not a single symptom. It is the visible surface of a multi-system physiological disturbance. The term persists because it is convenient, not because it is accurate. It implies a single cause, a temporary inconvenience, and a straightforward resolution: drink water, take a painkiller, eat something, sleep it off. But that model fails to explain the actual experience: why anxiety persists after alcohol has cleared, why cognitive function lags behind subjective recovery, and why two people who consumed the same amount can feel radically different the next day. It fails even more obviously in the context of modern nightlife. For someone who used MDMA on Saturday night, the most significant impairment may not appear until midweek — a delayed neurochemical consequence that is routinely misattributed to stress, work, or poor sleep rather than to the original cause. These are not edge cases. They are predictable features of a system that is being described incorrectly. What follows a night of substance use is not a collection of independent symptoms, but the emergent result of simultaneous disruption across multiple biological systems. Understanding it means starting not with the symptoms, but with the underlying biochemistry and physiology.
To describe this as a systems-level problem is not just to say that it is complex. It is to say that the symptoms do not arise from a single cause, and cannot be understood or resolved in isolation. In a single-symptom model, each effect is matched to a cause — dehydration explains headache, sleep loss explains fatigue, low blood sugar explains weakness. But in reality, multiple processes are disrupted at the same time, and each one alters the behaviour of the others. Changes in cellular energy production affect neurotransmitter synthesis; electrolyte imbalances alter neuronal excitability; inflammation feeds back onto both. The experience that follows is not the sum of separate problems, but the output of an interacting system returning, unevenly and incompletely, toward equilibrium. This is why interventions that target a single mechanism often produce limited or inconsistent results. They act on one part of a system whose behaviour is determined by many.
How Alcohol Initiates System Disruption
The disruption begins the moment alcohol enters the bloodstream. Its metabolism is not a neutral process — it actively alters the chemical environment in which cells operate. Most alcohol is processed through a pathway that converts ethanol into acetaldehyde, a highly reactive intermediate, and then into acetate. This process places immediate pressure on the cell’s redox balance, shifting the ratio of NAD⁺ to NADH and constraining the pathways that generate cellular energy. A secondary metabolic route becomes more active at higher levels of consumption. Unlike the primary pathway, this route directly generates reactive oxygen species as a byproduct, introducing oxidative stress alongside the existing metabolic disruption.
These two processes — redox imbalance and oxidative stress — are not independent. Together, they create the conditions for widespread physiological disturbance, affecting energy production, cellular integrity, and signalling systems across the body. This cascade does not occur in isolation. It unfolds in a system already shaped by sleep disruption, nutritional state, and — in many real-world contexts — the simultaneous effects of other substances. Even in the simplest case, alcohol alone is sufficient to disrupt multiple interacting systems. In combination, those disruptions compound.
|
Mechanistic Detail: Ethanol is metabolised primarily via alcohol dehydrogenase (ADH), which converts ethanol to acetaldehyde, followed by aldehyde dehydrogenase (ALDH2), which converts acetaldehyde to acetate. Both reactions reduce NAD⁺ to NADH, significantly altering the cellular NADH/NAD⁺ ratio. This shift has system-wide consequences. Elevated NADH inhibits key metabolic pathways, including glycolysis and the citric acid cycle, by limiting the availability of NAD⁺ required for dehydrogenase reactions. A secondary pathway — the microsomal ethanol-oxidising system (MEOS), mediated by cytochrome P450 2E1 (CYP2E1) — becomes increasingly active during heavy or chronic alcohol use. Unlike ADH, CYP2E1 activity produces reactive oxygen species (ROS) directly through electron leakage during catalysis. Acetaldehyde itself is highly reactive, forming adducts with proteins, lipids, and DNA, contributing to mitochondrial dysfunction and cellular stress. Together, these pathways generate a dual insult: disruption of cellular redox balance and increased oxidative load[1]. |
Four Dimensions of Disruption
The biological consequences of a night of heavy drinking — or of consuming other neuroactive substances with overlapping metabolic and pharmacological effects — can be understood across four interacting dimensions. Each has its own primary mechanism, its own timeline, and its own characteristic symptoms. These dimensions are not independent. They influence one another, amplify one another, and resolve at different rates. The state that follows is not the result of a single dominant process, but the combined behaviour of all four. This framework is not merely descriptive. Each dimension maps onto specific, measurable biochemical and physiological processes, providing a structured way to understand how a single night produces effects that unfold across hours to days.
1. Neurochemical: Excitatory–Inhibitory Imbalance and Neurotransmitter Depletion
Alcohol acts on the brain within minutes, shifting the balance between its primary inhibitory and excitatory systems. It enhances inhibitory signalling while simultaneously suppressing excitatory activity, producing the familiar effects of relaxation, reduced anxiety, and behavioural disinhibition. This is not a subtle modulation — it is a pharmacological shift in the brain’s fundamental operating balance.
The brain does not passively accept this state. It begins compensating almost immediately. Inhibitory signalling becomes less responsive, while excitatory systems are upregulated in an attempt to restore equilibrium. With repeated or heavy exposure, these compensatory changes become more pronounced. The neurochemical component of post-party malaise begins as alcohol levels fall. The temporary support for inhibitory signalling is removed, but the compensatory increase in excitatory activity remains. The result is a rebound state: heightened neuronal excitability, restlessness, anxiety, and increased sensitivity to sensory input. What felt like calm the night before is replaced by a system that is now temporarily overactive.
Alongside this, alcohol disrupts the brain’s monoamine systems. Dopamine release increases during intoxication, contributing to reward and reinforcement. As alcohol is cleared, dopamine levels fall below baseline, contributing to low mood, reduced motivation, and anhedonia. Serotonergic function is also affected, further shaping mood and emotional regulation in the post-drinking period. While alcohol provides the clearest example of this excitatory–inhibitory imbalance, other commonly used substances disrupt the same systems through different mechanisms. Stimulants and empathogens, for example, alter monoamine signalling more directly, producing neurochemical effects that follow different timelines but converge on similar post-use states of imbalance.
These effects are not psychological reactions to a poor night’s sleep or regretted decisions. They are the direct consequence of a neuromodulatory system that has been pharmacologically pushed away from equilibrium and is now returning — unevenly, slowly, and incompletely — toward baseline.
|
Mechanistic Detail: Ethanol enhances inhibitory neurotransmission primarily through positive allosteric modulation of GABA-A receptors, increasing chloride conductance and reducing neuronal excitability [2]. At the same time, it inhibits NMDA-type glutamate receptors, suppressing excitatory signalling. In response, the brain engages compensatory mechanisms. GABA-A receptor subunit composition shifts — with reductions in α1 and increases in α4 subunits — decreasing receptor sensitivity. NMDA receptors are upregulated, particularly NR2A and NR2B subunits in cortical and hippocampal regions [2, 3]. As blood alcohol concentration declines, the enhanced inhibitory signalling is withdrawn while the upregulated excitatory system remains active, producing a rebound increase in neuronal excitability. Ethanol also modulates monoaminergic systems. It increases dopamine release in the nucleus accumbens via disinhibition of dopaminergic neurons in the ventral tegmental area [4]. Following clearance, dopamine levels fall below baseline. Serotonin synthesis is also impaired, in part through effects on tryptophan availability and tryptophan hydroxylase activity [5]. Together, these changes contribute to the characteristic post-intoxication state of anxiety, low mood, reduced motivation, and heightened sensory sensitivity. |
2. Metabolic: The Disruption of Cellular Energy Production
Alcohol metabolism directly disrupts the machinery that produces cellular energy. As ethanol is processed, it drives a rapid shift in the balance between NAD⁺ and NADH — a central redox pair required for multiple stages of energy metabolism. As NADH accumulates and NAD⁺ becomes limited, the pathways that generate ATP begin to slow.
This has system-wide consequences. Glycolysis becomes constrained, the entry of pyruvate into the TCA cycle is impaired, and mitochondrial energy production is reduced. Instead of being efficiently converted into usable energy, metabolic intermediates are diverted into less productive pathways, including lactate formation. The disruption does not stop at substrate availability. Mitochondrial function itself is compromised. Acetaldehyde and associated oxidative stress impair the integrity of the inner mitochondrial membrane, reducing the efficiency of the electron transport chain and increasing electron leakage. At the same time, fuel delivery becomes less effective. The transport systems that allow fatty acids to enter mitochondria for oxidation are impaired, while upstream constraints limit the conversion of glucose into usable substrates. The result is a system in which both fuel supply and energy generation are restricted. The subjective consequence is fatigue that does not resolve with rest. The limitation is not sleep, but cellular energy availability. Every energy-dependent process — from muscle function to neurotransmitter synthesis — is operating under constraint.
|
Mechanistic Detail: Ethanol metabolism via alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) converts NAD⁺ to NADH at high rates, significantly increasing the NADH/NAD⁺ ratio [1]. This alters the redox state of the cell and inhibits key metabolic pathways. Elevated NADH suppresses glycolysis by limiting the availability of NAD⁺ required for glyceraldehyde-3-phosphate dehydrogenase. It also impairs the conversion of pyruvate to acetyl-CoA via the pyruvate dehydrogenase complex, diverting pyruvate toward lactate production. Entry into the TCA cycle is further constrained by cofactor availability, including thiamine (B1), which is required for pyruvate dehydrogenase activity, and other vitamin-derived cofactors involved in oxidative metabolism [26]. Within mitochondria, acetaldehyde and reactive oxygen species disrupt membrane integrity and impair the electron transport chain. Coenzyme Q (Q10) functions as a mobile electron carrier within this system and is sensitive to oxidative and structural disruption, reducing ATP production efficiency. Fatty acid oxidation is also impaired. Long-chain fatty acids require the carnitine shuttle (CPT1/CPT2) to enter mitochondria, and acetaldehyde-mediated modifications to these enzymes reduce transport efficiency [6]. In severe cases, mitochondrial permeability transition can occur, uncoupling oxidative phosphorylation and further reducing ATP generation [6]. The combined effect is a reduction in ATP availability across multiple pathways, producing a systemic energy deficit. |
3. Electrolytic: The Disruption of Ion Homeostasis
Alcohol disrupts fluid balance through a well-defined physiological mechanism, increasing urine output and reducing the body’s ability to retain water. But the consequence is not simply dehydration. The loss extends beyond fluid to the ions and osmolytes that regulate cellular function.
Magnesium, potassium, and sodium are depleted through a combination of increased excretion and impaired reabsorption. These are not passive losses. They directly affect processes that depend on electrical gradients and energy availability, including neuronal signalling and muscle function. At the same time, the systems responsible for maintaining these gradients are themselves under strain. Ion transport depends on ATP, and ATP production is already compromised by the metabolic disruption described earlier. As a result, the body is not only losing key ions, but also less able to redistribute and utilise what remains. The effect is systemic. Changes in electrolyte balance alter neuronal excitability, intersect with the neurochemical dimension, and contribute to symptoms such as restlessness, fatigue, and sensitivity to sensory input.
Replacing fluid alone does not resolve this. The problem is not simply water loss, but disruption of the electrochemical environment on which cellular function depends. Rehydration and restoration of ion balance are not equivalent processes.
|
Mechanistic Detail: Ethanol inhibits the release of vasopressin (antidiuretic hormone, AVP) by interfering with calcium-dependent vesicular release in the posterior pituitary [7]. Reduced vasopressin signalling decreases aquaporin-2 expression in the kidney collecting ducts, reducing water reabsorption and increasing urine output. This diuresis is accompanied by electrolyte loss. Magnesium reabsorption is impaired both by direct renal effects of ethanol and by competition from lactate produced during NADH-driven metabolic shifts [8]. Potassium and sodium are also depleted through increased excretion and sweating. These ions are critical for maintaining electrochemical gradients. Magnesium, in particular, is required for Mg-ATP formation and plays a role in regulating ion channels, including NMDA receptors. Alcohol also increases the excretion of organic osmolytes such as taurine. Taurine contributes to cell volume regulation, mitochondrial stability, and inhibitory neurotransmission through interactions with GABA-A receptors. Its depletion may therefore intersect with both metabolic and neurochemical disruption. Together, these changes impair the body’s ability to maintain cellular homeostasis across multiple systems. |
4. Oxidative: Redox Disruption and the Inflammatory Response
In parallel with metabolic and neurochemical disruption, alcohol increases oxidative stress — a state in which reactive oxygen species are produced faster than the body can neutralise them. One of the pathways involved in alcohol metabolism generates these reactive molecules directly. Unlike the primary metabolic route, this pathway leaks electrons during its activity, producing unstable oxygen species that can damage lipids, proteins, and DNA. At the same time, the systems responsible for containing this damage are weakened. The cell’s antioxidant capacity is reduced, both through increased consumption and impaired regeneration. The balance between oxidant production and defence shifts toward accumulation of damage.
This does not remain a local effect. Oxidative stress alters the integrity of the intestinal barrier, increasing permeability and allowing bacterial components to enter circulation. These signals activate immune pathways, leading to the release of inflammatory cytokines. These cytokines are measurable in the bloodstream during hangover and correlate with symptom severity. Some even cross the blood brain barrier, where they activate immune cells and contribute to neuroinflammation. The result is a state that extends beyond cellular damage to systemic inflammation — contributing to fatigue, cognitive slowing, and the diffuse sense of malaise that characterises the post-party state.
|
Mechanistic Detail: The CYP2E1 pathway of ethanol metabolism generates reactive oxygen species (ROS) through electron leakage during catalytic cycling, producing superoxide (O₂•⁻) [1]. Superoxide is converted to hydrogen peroxide (H₂O₂), which in the presence of iron can generate hydroxyl radicals (•OH) via Fenton chemistry. Acetaldehyde further amplifies oxidative stress by forming adducts with glutathione (GSH), depleting intracellular antioxidant reserves. During heavy alcohol exposure, hepatic GSH levels can decrease by 30–50% [9, 10]. Antioxidant defence systems become substrate- and cofactor-limited. These include glutathione-dependent enzymes such as glutathione peroxidase (GPx), as well as superoxide dismutases (SOD1 and SOD2), which require metal cofactors for activity. Non-enzymatic antioxidants operate across cellular compartments. Ascorbic acid (vitamin C) scavenges reactive species in aqueous environments and regenerates oxidised vitamin E, while alpha-tocopherol (vitamin E) protects lipid membranes from peroxidation. Carotenoids contribute to singlet oxygen quenching [25]. Oxidative stress also disrupts intestinal tight junction proteins such as ZO-1, increasing gut permeability. This permits translocation of lipopolysaccharide (LPS) from gram-negative bacteria into circulation, activating toll-like receptor 4 (TLR4) signalling in hepatic macrophages [11, 23]. TLR4 activation initiates downstream signalling via MyD88/TRIF pathways, leading to NF-κB activation and transcription of pro-inflammatory cytokines including IL-6, TNF-α, and IL-1β. These cytokines are elevated during hangover and correlate with symptom severity [11]. IL-6 can cross the blood–brain barrier and activate microglia, contributing to neuroinflammation and cognitive impairment. The endotoxemia-to-inflammation pathway is supported by multiple lines of evidence [23]. |
Sleep Disruption: Amplifying and Prolonging Disruption
Sleep is not merely a consequence of post-party physiology — it is a systems-wide amplifier that determines how severely each dimension compounds, and how slowly each resolves. Alcohol disrupts sleep architecture from the first hours of the night. Although it can accelerate sleep onset, it suppresses REM sleep and fragments the second half of the night as blood alcohol levels fall. The result is a pattern of early waking, increased physiological arousal, and a rebound of the excitatory state that was suppressed during intoxication. Even moderate amounts of alcohol produce measurable disruption to REM sleep in a dose-dependent manner [14].
The subjective experience is familiar: waking in the early hours not because sleep is complete, but because sedation has worn off. The resulting sleep is fragmented and non-restorative, and is followed by a morning in which every dimension of the cascade is operating in the context of sleep deprivation.
This matters because sleep loss does not act in isolation. It amplifies each of the systems already under strain. It increases oxidative stress, elevates inflammatory signalling, and worsens neurochemical instability. At the same time, it impairs the processes that support recovery, including metabolic restoration and the clearance of inflammatory byproducts from the brain. The interaction runs in both directions. Disrupted sleep worsens the underlying physiology, and the underlying physiology makes subsequent sleep more difficult. As a result, recovery is not reset overnight. It unfolds across multiple days in a system that remains partially sleep-deprived.
|
Mechanistic Detail: Alcohol suppresses REM sleep in a dose-dependent manner and increases slow-wave sleep in the first half of the night, followed by fragmentation in the second half as blood alcohol levels decline [14, 15]. This is associated with increased sympathetic nervous system activity, elevated core body temperature, and rebound excitatory neurotransmission. Sleep deprivation independently increases oxidative stress, elevates cortisol and inflammatory cytokines, and impairs glymphatic clearance — the process by which metabolic waste is removed from the brain during sleep. These effects overlap with and amplify the metabolic, oxidative, and neurochemical disruptions induced by alcohol. |
System Disruptions Are Not Independent
What makes post-party malaise difficult to understand is not the severity of any single disruption, but the way they interact. The four dimensions do not operate in isolation. Each one alters the others. Disruption to energy production impairs the systems that contain oxidative stress. Oxidative stress, in turn, damages cellular structures and amplifies inflammatory signalling. Electrolyte imbalance affects neuronal excitability and the energy-dependent processes required to restore it. Neuroinflammation feeds back onto neurotransmitter systems, further destabilising mood and cognition. Sleep disruption cuts across all of these, worsening each dimension while simultaneously impairing the processes that would allow them to recover.
The result is not a set of independent problems, but a system of interacting ones. The severity of the experience reflects not just how much each system is disrupted, but how strongly those disruptions reinforce one another. This is why outcomes vary so widely between individuals. Differences in metabolism, baseline physiology, and sleep can shift how far these feedback loops propagate. What appears unpredictable is simply the behaviour of an interacting system responding to different starting conditions.
Symptoms As System Readouts
With this framework in place, the symptoms of post-party malaise can be understood differently. They are not isolated problems to be treated individually, but signals reflecting which systems are most disrupted. Headache, for example, reflects a convergence of processes — vascular changes, disrupted fluid and electrolyte balance, and neuroinflammatory signalling. Nausea emerges from both direct effects on the gastrointestinal system and systemic inflammatory responses. Anxiety and low mood reflect neurochemical imbalance, particularly the shift in excitatory–inhibitory signalling and depletion of monoamine systems. Cognitive fog arises from the combined effects of neuroinflammation, impaired neurotransmission, and reduced energy availability in the brain. Fatigue is not simply tiredness, but a bioenergetic signal — a system operating under constrained ATP production.
These functional impairments have been directly measured. A systematic review of 19 studies found that hangover consistently impairs psychomotor speed, short- and long-term memory, and sustained attention — including in conditions where blood alcohol concentration has fully returned to zero [16]. The encoding of new information is particularly vulnerable: decision-making, learning, and problem-solving are affected at a level the person experiencing them may not recognise as impairment.This creates a mismatch between perception and function. The subjective sense of recovery often precedes full cognitive recovery. Because these symptoms arise from different underlying processes, addressing them individually produces limited results. A painkiller may attenuate headache but does not touch the neurochemical rebound, the NAD+ deficit, or the oxidative burden. Caffeine provides neurological stimulation without restoring any of the underlying metabolic, oxidative, or neurochemical systems.
Overlapping Effects: How Different Substances Extend Disruption
While alcohol provides a clear starting point, the same framework applies more broadly. In real-world settings, substance use is rarely isolated. Alcohol is often combined with other compounds that act on the same biological systems through different mechanisms and on different timelines. These effects are not simply additive. They overlap and interact within the same underlying systems — altering neurochemical balance, energy production, oxidative load, and inflammatory signalling in ways that extend and compound the recovery process.
MDMA, for example, produces a large acute release of serotonin by reversing the serotonin transporter (SERT), flooding the synapse with neurotransmitter. What follows is a depletion of intracellular serotonin stores that cannot be rapidly restored, as synthesis is rate-limited by precursor availability and enzyme kinetics. As a result, the most significant neurochemical consequence of MDMA use does not occur the next morning, but several days later. In controlled studies, mood is significantly reduced days after use, with a peak in impairment often occurring midweek rather than immediately after the event [17, 18].
Cocaine acts differently but converges on the same systems. By blocking dopamine, norepinephrine, and serotonin transporters, it produces an acute increase in monoamine signalling followed by a crash as neurotransmitter availability falls. This crash typically emerges within hours, meaning that it can overlap directly with the peak of the alcohol hangover. When combined with alcohol, an additional metabolite — cocaethylene — is formed, extending both the neurochemical and physiological burden beyond that of either substance alone.
Ketamine introduces a further layer. Through NMDA receptor antagonism, it suppresses excitatory signalling during intoxication. However, its cognitive effects can persist well beyond the acute phase, with impairments in memory and perception measurable days after use [21]. This extends the period of dysfunction into the early part of the week.
The result is a distributed pattern of disruption. Alcohol produces a peak in impairment the following morning. Cocaine adds an overlapping crash within hours. Ketamine extends cognitive effects into subsequent days. MDMA shifts part of the neurochemical cost several days later. What emerges is not a single recovery curve, but a staggered one. Different systems are disrupted at different times, and recovery is spread across a longer window than the immediate aftermath suggests. This is why the effects of a single night often extend beyond what is recognised. The cost is not confined to the next morning, but distributed across the following days in ways that are rarely attributed to their original cause.
The 120-Hour Recovery Timeline: Shifting Systems Across Days
One of the most persistent errors in how post-party malaise is understood is its timeframe. Recovery is assumed to be complete by Sunday evening — once the acute effects of the night have passed. In reality, the physiological consequences unfold across a much longer window. While the exact duration varies, the combined effects of commonly used substances can extend across a period of up to four to five days — a useful approximation for understanding how recovery unfolds over time.
The first phase is immediate. In the hours following a night out, alcohol metabolism continues, sleep is disrupted, and multiple systems begin to shift simultaneously. By Sunday morning, these effects converge: neurochemical rebound, metabolic constraint, electrolyte imbalance, and inflammatory signalling are all near their peak. This is what is typically recognised as a “hangover.” Importantly, this process does not begin the following morning. The underlying disruptions are initiated during the night itself — as metabolism shifts, neurotransmitter systems are perturbed, and oxidative and inflammatory pathways are activated in real time. By the point at which symptoms are subjectively recognised, these processes are already well underway. This has implications not only for how the experience is understood, but for when meaningful intervention would need to occur.
What follows is less visible. From Sunday onward, some processes begin to resolve, but not all at the same rate. Cognitive and physiological recovery is uneven. Sleep disruption carries forward, and residual effects persist into the start of the week. The most important change, however, occurs later. For certain substances, particularly MDMA, the primary neurochemical consequences do not peak the next day, but several days after use. By midweek, mood, motivation, and cognitive function can reach their lowest point — a delayed effect that is rarely linked back to the original event.
This creates a systematic misattribution. Sunday’s impairment is recognised and correctly attributed. Midweek impairment is not. The result is a distorted picture of recovery. The cost of a single night is underestimated because it is measured against the wrong timeframe. What appears to be a short-lived effect is, in reality, distributed across multiple days, with different systems dominating at different points. Recovery is therefore not a single event, but a temporal process — one that unfolds unevenly, and often invisibly, beyond the period in which it is typically acknowledged.
Toward a Systems-Level Model of Post-Party Malaise
What emerges from this framework is not a list of symptoms, but a model. Post-party malaise is best understood not as a single condition, but as the behaviour of an interacting biological system under constraint. Multiple physiological domains — neurochemical, metabolic, electrolytic, and inflammatory — are disrupted simultaneously, each evolving over time and each influencing the others. The state that follows is not reducible to any one of them.
This has two consequences. First, the experience is inherently non-linear. The severity of symptoms does not track cleanly with any single variable — not blood alcohol concentration, not hours of sleep, not hydration status. Instead, it reflects the combined state of multiple systems, each recovering at a different rate. Small differences in initial conditions — nutritional state, sleep, metabolic capacity — can therefore produce disproportionately different outcomes. Second, recovery is uneven. There is no single point at which the system returns to baseline. Different processes resolve on different timescales, and the subjective sense of recovery may not correspond to full physiological restoration. At any given moment, one system may have stabilised while another remains impaired.
This reframes both the experience and the response to it. If post-party malaise arises from the interaction of multiple disrupted systems, then approaches that focus on a single mechanism — or that target symptoms in isolation — will necessarily be limited. They act on one part of a system whose behaviour is determined by many.
A systems-level model does not eliminate this complexity, but it makes it tractable. It provides a structure for understanding why the experience unfolds as it does, why it varies between individuals, and why it often persists beyond the timeframe in which it is typically acknowledged. This is not a complete account. It is a starting point — a way of replacing a simplified model with one that better reflects the underlying biology, and of understanding post-party malaise not as a short-lived inconvenience, but as a coordinated process unfolding across interacting systems over time.
References
[1] Lu Y, Cederbaum AI. CYP2E1 and oxidative liver injury by alcohol. Free Radical Biology and Medicine. 2008;44(5):723–738. doi:10.1016/j.freeradbiomed.2007.11.004. PMCID: PMC2268632
[2] Enoch MA. The role of GABA(A) receptors in the development of alcoholism. Pharmacology, Biochemistry and Behavior. 2008;90(1):95–104. doi:10.1016/j.pbb.2008.03.007. PMID: 18440057
[3] Ron D, Wang J. The NMDA receptor and alcohol addiction. In: Van Dongen AM, ed. Biology of the NMDA Receptor. CRC Press/Taylor & Francis; 2009. Chapter 4. URL: https://www.ncbi.nlm.nih.gov/books/NBK5284/
[4] Appel SB, Liu Z, McElvain MA, et al. Ethanol effects on dopaminergic reward neurons in the ventral tegmental area and the mesolimbic pathway. Alcoholism: Clinical and Experimental Research. 2004;28(11):1676–1684. doi:10.1097/01.ALC.0000145976.64413.21
[5] Badawy AAB. Tryptophan metabolism in alcoholism. Nutrition Research Reviews. 2002;15(1):123–152. doi:10.1079/NRR200133
[6] Hoek JB, Cahill A, Pastorino JG. Alcohol and mitochondria: a dysfunctional relationship. Gastroenterology. 2002;122(7):2049–2063. doi:10.1053/gast.2002.33613. PMCID: PMC1868435
[7] Antunes-Rodrigues J, de Castro M, Elias LLK, Valença MM, McCann SM. Neuroendocrine control of body fluid metabolism. Physiological Reviews. 2004;84(1):169–208. doi:10.1152/physrev.00017.2003. PMID: 14715914
[8] de Marchi S, Cecchin E, Basile A, et al. Renal tubular dysfunction in chronic alcohol abuse — effects of abstinence. New England Journal of Medicine. 1993;329(26):1927–1934. doi:10.1056/NEJM199312233292605. PMID: 8247056
[9] Suresh MV, et al. Cysteine and glutathione prevent ethanol-induced hangover through aldehyde neutralization. Antioxidants. 2023;12(10):1885. doi:10.3390/antiox12101885
[10] Khoshbouei H, et al. Glutathione administration and hangover symptom severity: a randomised controlled trial. Nutrients. 2024;16(19):3262. doi:10.3390/nu16193262
[11] van de Loo AJAE, Mackus M, Kwon O, et al. The inflammatory response to alcohol consumption and its role in the pathology of alcohol hangover. Journal of Clinical Medicine. 2020;9(7):2081. doi:10.3390/jcm9072081. PMCID: PMC7408936
[12] Colado MI, O'Shea E, Granados R, et al. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy'). British Journal of Pharmacology. 1997;121(5):889–900. doi:10.1038/sj.bjp.0701213. PMID: 9222545
[13] Ricaurte GA, Mechan AO, Yuan J, et al. Amphetamine treatment damages dopaminergic nerve endings in the striatum of adult nonhuman primates. Journal of Pharmacology and Experimental Therapeutics. 2005;315(1):91–98. doi:10.1124/jpet.105.087916. PMID: 15987829
[14] Gardiner C, Weakley J, Burke LM, et al. The effect of alcohol on subsequent sleep in healthy adults: a systematic review and meta-analysis. Sleep Medicine Reviews. 2024;80:102030. doi:10.1016/j.smrv.2024.102030. PMID: 39631226
[15] Colrain IM, Nicholas CL, Baker FC. Alcohol and the sleeping brain. Handbook of Behavioral Neurobiology. 2014. PMCID: PMC5821259
[16] Gunn C, Mackus M, Griffin C, Munafò MR, Adams S. A systematic review of the next-day effects of heavy alcohol consumption on cognitive performance. Addiction. 2018;113(9):2182–2193. doi:10.1111/add.14404. PMID: 30144191
[17] Curran HV, Travill RA. Mood and cognitive effects of ±3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end high followed by mid-week low. Addiction. 1997;92(7):821–831. PMID: 9293041
[18] Verheyden SL, Hadfield J, Calin T, Curran HV. Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences. Psychopharmacology. 2002;161(1):23–31. doi:10.1007/s00213-001-0952-7. PMID: 11967628. [REPLACED 2026-03-24: Original (Lemmers-Jansen 2025) could not be verified — no publication found despite multiple searches. Claim about post-MDMA mood dip on days 2-3 is supported by this verified study and by [17] Curran & Travill 1997.]
[19] Parrott AC, Lasky J. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology. 1998;139(3):261–268. PMID: 9784083
[20] Gawin FH, Kleber HD. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Archives of General Psychiatry. 1986;43(2):107–113. PMID: 3947207
[21] Curran HV, Morgan CJA. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and three days later. Addiction. 2000;95(4):575–590. PMID: 10829333
[22] Measham F, Moore K. Repertoires of distinction: exploring patterns of weekend polydrug use within local leisure scenes across the English night time economy. Criminology and Criminal Justice. 2009;9(4):437–464.
[23] Turner J, Mackus M, Arnoldy L, et al. The role of inflammation and oxidative stress in the pathology of alcohol hangover. Alcoholism: Clinical and Experimental Research. 2024. doi:10.1111/acer.15396
[24] Thakkar MM, Sharma R, Sahota P. Alcohol disrupts sleep homeostasis. Alcohol. 2015;49(3):299–310. PMCID: PMC4427543
[25] Nishida Y, Yamashita E, Miki W. Quenching activities of common hydrophilic and lipophilic antioxidants against singlet oxygen using chemiluminescence detection system. Carotenoid Science. 2007;11:16–20.
[26] Butterworth RF. Thiamine deficiency and brain disorders. Nutrition Research Reviews. 2003;16(2):277–284. doi:10.1079/NRR200367. PMID: 19087395
0 comments